Commentary
MM Asfari et al. aimed to evaluate the association between polycystic ovarian syndrome and NAFLD using a large national database.
Adult female patients (≥18 years) with polycystic ovarian syndrome using the National Inpatient Sample database between 2002 and 2014. The control group included patients who did not have a diagnosis of polycystic ovarian syndrome. Out of a total of 50 785 354 women, 77 415 (0.15%) had polycystic ovarian syndrome. Patients with polycystic ovarian syndrome have four times higher risk of developing NAFLD compared with women without polycystic ovarian syndrome.
Further studies are needed to assess if specific polycystic ovarian syndrome treatments can affect NAFLD progression.
Previous Post
The changing global epidemiology of hepatocellular carcinoma
Next Post
Role of agents for the treatment of diabetes in the management of non-alcoholic fatty liver disease